Skip to main content

Table 2 The primary and secondary motor outcome measures after the real versus sham tDCS

From: Effects of bihemispheric transcranial direct current stimulation on motor recovery in subacute stroke patients: a double-blind, randomized sham-controlled trial

 

Real tDCS

Sham tDCS

rmANCOVA, p-value (η2)

 

T1

T2

T3

T1

T2

T3

Time

Group

Group-by-Time

Primary outcome

FMA-UE

31.8

(17.5)

45.4 (22.3)

50.9

(19.3)

30.6

(20.5)

38.8

(22.1)

40.2

(24.1)

 < 0.001

(0.392)

 < 0.001

(0.452)

 < 0.001

(0.327)

Secondary outcomes

ARAT

18.9

(15.3)

30.8

(22.1)

36.1

(20.5)

17.0

(18.2)

22.9

(22.7)

27.3

(25.5)

0.002

(0.285)

0.012

(0.234)

0.062

(0.122)

FMA-LE

20.5

(7.5)

27.5

(5.2)

30.3

(3.8)

22.3

(8.3)

27.1

(5.9)

28.6

(5.6)

 < 0.001

(0.81)

0.007

(0.264)

0.013

(0.165)

  1. ARAT Arm Research Action Test, FMA-UE/LE Fugl-Meyer Assessment of Upper extremity/Lower Extremity, rmANCOVA mixed-design, repeated measures analysis of covariance, T1 baseline, T2 post-intervention, T3 12 weeks after onset. The values represent the mean (standard deviation)